Clinical trial Recruiting at 1 site Interventional Ages 20 to 50

McGill Stabilization Exercises vs Sahrmann Movement-Based Exercises for Chronic Low Back Pain

Official title: Effects of McGill Versus Sahrmann's Protocol on Pain, Range of Motion and Disability in Chronic Non- Specific Low Back Pain

Run by Riphah International University · NCT07724704 · Data updated 2026-11-12

This trial tests whether McGill stabilization exercises or Sahrmann's movement-based exercises better reduce pain and improve motion and function in adults with chronic non-specific low back pain.

Quick facts

Study typeInterventional
Ages20 Years to 50 Years
SexAll
Enrollment40 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedJuly 16, 2026
Main results expectedSeptember 16, 2026
Study endsSeptember 16, 2026
Registry record updatedJuly 24, 2026
Trial IDNCT07724704 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 20–50 with chronic non-specific low back pain for at least 12 weeks and a baseline pain 3–4 on the NPRS, willing to participate in a structured exercise program.

Probably not a fit

Individuals with prior spinal surgery, neurological deficits, structural deformities, red flags, or contraindications to exercise may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, interventional study compares two exercise programs for adults with chronic non-specific low back pain lasting more than 12 weeks. Participants are assigned to either McGill stabilization exercises or Sahrmann's movement-based exercise protocol to see which approach better reduces pain, increases lumbar range of motion, and decreases disability. The trial uses standard outcome measures including pain intensity, lumbar mobility, and functional status to compare the two interventions over the treatment period. Conducted at Lahore-area clinics, the study adheres to safety and consent requirements and targets adults aged 20–50 without surgical history or red flags. The aim is to provide evidence to guide exercise-based rehabilitation for CNSLBP.

Why it matters

Potential benefit: If successful, the preferred exercise protocol could offer greater pain relief and functional improvement for people with chronic non-specific low back pain.

How similar studies have gone: Direct head-to-head comparisons of these two routines are limited, making this study a relatively novel contribution to the evidence base.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Adults aged 20-50 years.
* Male and female participants.
* Diagnosed with chronic non-specific low back pain lasting more than 12 weeks.
* Pain intensity of 3-4 on the Numeric Pain Rating Scale (NPRS) at baseline.
* Able and willing to participate in the exercise program and attend all treatment sessions.
* Willing to provide written informed consent.

Exclusion Criteria

* History of spinal surgery.
* Presence of neurological deficits.
* Structural spinal deformities.
* Pregnancy or within 6 months postpartum.
* Presence of red flag signs or systemic illness (e.g., fracture, infection, malignancy, inflammatory disorders).
* Individuals unable or unwilling to participate in the exercise program or complete the study protocol.

Where it's running

  • Lahore Clinic Shujabad, THQ Hospital Shujabad
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.